04/30/2025
10:23 AM | Keros Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
04/28/2025
5:43 PM | ADAR1 Capital Management, LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
04/23/2025
3:09 PM | Keros Therapeutics (Filer)
| Form ARS | |
04/23/2025
3:03 PM | Keros Therapeutics (Filer)
| Form DEF 14A | |
04/11/2025
8:57 PM | ADAR1 Capital Management GP, LLC (Reporting)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Keros Therapeutics (Issuer)
Schneeberger Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
7:58 PM | ADAR1 Capital Management GP, LLC (Reporting)
ADAR1 Capital Management, LLC (Reporting)
ADAR1 Partners, LP (Reporting)
Keros Therapeutics (Issuer)
Schneeberger Daniel (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2025
7:32 PM | ADAR1 Capital Management, LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13D | |
04/10/2025
5:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
5:04 AM | Keros Therapeutics (Filer)
| Form 8-A12B | |
04/07/2025
3:15 PM | Keros Therapeutics (Issuer)
Seehra Jasbir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
5:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for KROS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Keros Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
02/28/2025
4:01 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
9:23 AM | FMR LLC (Filed by)
Keros Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/30/2025
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
3:15 PM | Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
| Form 4/A | |
01/21/2025
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
5:31 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
7:00 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2024
5:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
6:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/26/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
3:18 PM | CHYUNG YUNG H. (Reporting)
Keros Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
3:22 PM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
7:00 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
4:06 PM | GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
4:01 PM | Keros Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:12 PM | Keros Therapeutics (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:02 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
4:15 PM | Keros Therapeutics (Filer)
| Form 424B5 | |
06/17/2024
4:17 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
5:07 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:10 PM | BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2024
3:11 PM | BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
3:15 PM | Farzan Nima (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | GRAY MARY ANN (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump Orders 'National Digital Asset Stockpile' (Ad) Billionaires Rush Into Digital Banking Token
Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days. Click Here to get our complete analysis on why this lending platform is our #1 "buy the dip" opportu |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Knowles Julius (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Nussbaum Ran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Kariv Tomer (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Seth Alpna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:03 AM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
7:00 AM | Keros Therapeutics (Filer)
| Form S-3ASR | |
Buy KROS Stock Free KROS Stock Alerts